Thursday 29 May, 2025
8am EDT (Eastern) / 1pm BST (UK) / 2pm CEST (EU-Central)
Duration: 60 minutes
Dr. Luke Zhou, CEO, Santo Therapeutics
The Potential of Microfluidics Technology in Cell and Gene Therapy
Unlocking the next frontier of scalable, in vivo therapeutics with single-cell precision
As the cell and gene therapy (CGT) field matures, a transformative shift is underway – from complex, ex vivo approaches to patient-centric, in vivo therapeutic delivery. This expert-led webinar explores how microfluidics technology is catalyzing this evolution, offering scalable, high-throughput solutions for next-generation gene therapy development.
Join Dr. Luke Zhou, Founder & CEO of Santo Therapeutics, as he shares insights from a first-in-human clinical trial targeting NF2-related tumors and demonstrates how microfluidics platforms like Cyto-Mine® are enabling stable vector-producing cell lines fit for in vivo CAR-T and gene editing applications.
Discover how single-cell analysis and intelligent clone selection are reshaping the therapeutic landscape, making cell and gene therapies faster to develop, more scalable, and accessible to more patients.
In this webinar, you’ll learn how to:
Register Now!
Reserve your spot now and be part of the conversation shaping the future of in vivo gene therapy.
Meet The Expert
Dr. Luke Zhou
Founder & CEO, Santo Therapeutics
Dr. Zhou holds a PhD in Biochemistry from Heriot-Watt University and has over a decade of experience in cancer research, gene therapy, and therapeutic vector development.
His work has been featured in leading journals like Oncogene, Cell, and Cancer Cell, and recognized by Forbes China, Cancer Research UK, and the Children’s Brain Tumor Foundation.
As a thought leader in microfluidics-enabled CGT innovation, Dr. Zhou continues to pioneer scalable solutions for gene therapy and immuno-oncology.
The Next Generation: Cyto-Mine® Chroma
Automate. Accelerate. Analyze millions of cells in a single day.
Think Cyto-Mine®, but supercharged, enabling multiplexing and greater assay flexibility to fit your needs. It means that you can examine vastly greater numbers of cells — and isolate the most valuable ones— with unparalleled precision.
